Abstract

To determine if there are any differences in the zonal distribution and tumor volumes of familial and sporadic prostate cancers (PC) in men undergoing radical prostatectomy. 839 patients underwent a radical prostatectomy in the absence of prior neoadjuvant therapy between 1987 and 1996. Telephone interviews were conducted to obtain an updated family history. A positive family history was defined as the diagnosis of PC in at least one first degree relative. Prostatectomy specimens were examined to determine the number of tumor foci, zonal origin of the dominant tumor focus, tumor volume of the largest cancer focus, total tumor volume, Gleason score and stage, and the surgical margin status. Results were stratified according to family history and ethnicity. We successfully contacted 437 patients (52%). Prostatectomy specimens from 55 patients were excluded from review due to a history of prior transurethral resection of the prostate (n = 26) or uncertain pathological stage (n = 29). Of the remaining 382 patients, 76 (20%) reported having a first-degree relative with PC. Statistical analysis revealed no significant differences in the pathologic variables between the two groups of patients with or without a family history of PC. Familial and sporadic PC share similar characteristics. No histopathological differences account for the increased positive predictive value of PC screening tests among patients with a family history of PC.

Highlights

  • The reported rate of positive family history among men with prostate cancer (PC) ranges from 13% to 26% and approaches 40% for men diagnosed with the disease before age 55 [1,2,3]

  • There are no pathologic data that explain the increased positive-predictive value reported for abnormal digital rectal examination (DRE) and prostate-specific antigen (PSA) tests in high-risk patients, such as those with a positive family history [10,11]

  • We examined the zonal distribution of cancer foci, tumor location, and tumor volume differences of our surgically managed patients with and without a family history of PC

Read more

Summary

INTRODUCTION

The reported rate of positive family history among men with prostate cancer (PC) ranges from 13% to 26% and approaches 40% for men diagnosed with the disease before age 55 [1,2,3]. We hypothesized that RP specimens from patients with a family history of PC might reveal different tumor characteristics compared with specimens from patients with sporadic PC and that the different characteristics could account for the higher diagnostic yield of prostate biopsies performed in patients with risk factors for disease. To address this hypothesis, we examined the zonal distribution of cancer foci, tumor location, and tumor volume differences of our surgically managed patients with and without a family history of PC. We analyzed corresponding clinicopathologic data, such as age, preoperative PSA levels, pathologic stage, Gleason score, and surgical margin status in patient groups stratified by family history

MATERIALS AND METHODS
RESULTS
CONCLUSIONS
Bratt O
16. Gleason D
18. Crawford ED
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call